Clinical outcomes following discontinuation of metformin in patients with type 2 diabetes and advanced chronic kidney disease in Hong Kong: a territory-wide, retrospective cohort and target trial emulation study

Clinical outcomes following discontinuation of metformin in patients with type 2 diabetes and advanced chronic kidney disease in Hong Kong: a territory-wide, retrospective cohort and target trial emulation study

Current labelling advises discontinuation of metformin when estimated glomerular filtration rate (eGFR) 

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EClinicalMedicine 2024-05, Vol.71, p.102568-102568, Article 102568
Hauptverfasser: Yang, Aimin, Shi, Mai, Wu, Hongjiang, Lau, Eric SH, Cheung, Johnny TK, Zhang, Xinge, Fan, Baoqi, Chen, Tingting, Kong, Alice PS, Luk, Andrea OY, Ma, Ronald CW, Chan, Juliana CN, Chow, Elaine
Format: Artikel
Sprache:eng
Schlagworte:
Cardiovascular disease
Chronic kidney disease
Diabetes
Lactic acidosis
Metformin
Mortality
Therapeutics
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Current labelling advises discontinuation of metformin when estimated glomerular filtration rate (eGFR) 
ISSN:2589-5370
2589-5370
DOI:10.1016/j.eclinm.2024.102568